Pinnacle Medicines

Pinnacle Medicines is a biotechnology company focused on developing a new generation of oral peptide therapeutics, aiming to achieve biologic-level efficacy through convenient oral dosing. The company is building a differentiated discovery platform that integrates physics-based molecular simulation, AI-driven design, and advanced peptide chemistry technologies to rationally design and optimize peptide drugs. Pinnacle is advancing a series of potentially first-in-class oral peptide programs targeting validated pathways in immunology and cardiometabolic diseases.